Altium Capital Management LP Milestone Pharmaceuticals Inc. Transaction History
Altium Capital Management LP
- $283 Million
- Q3 2024
A detailed history of Altium Capital Management LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 440,000 shares of MIST stock, worth $818,400. This represents 0.24% of its overall portfolio holdings.
Number of Shares
440,000
Previous 1,012,368
56.54%
Holding current value
$818,400
Previous $1.34 Million
50.0%
% of portfolio
0.24%
Previous 0.71%
Shares
3 transactions
Others Institutions Holding MIST
# of Institutions
44Shares Held
28.6MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$9.25 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$6.06 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5.17 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.94 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$3.83 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $55.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...